Other Earnings and Cash Flow Stats:
BIO-RAD LABORATORIES INC. ( BIO ) Net Income TTM ($MM) is -778.70
BIO-RAD LABORATORIES INC. ( BIO ) Operating Income TTM ($MM) is 308.46
BIO-RAD LABORATORIES INC. ( BIO ) Owners' Earnings Annual ($MM) is 0.00
BIO-RAD LABORATORIES INC. ( BIO ) Current Price to Owners' Earnings ratio is 0.00
BIO-RAD LABORATORIES INC. ( BIO ) EBITDA TTM ($MM) is 324.76
BIO-RAD LABORATORIES INC. ( BIO ) EBITDA Margin is 6.27%
Capital Allocation:
BIO-RAD LABORATORIES INC. ( BIO ) has paid 0.00 dividends per share and bought back 0.937 million shares in the past 12 months
BIO-RAD LABORATORIES INC. ( BIO ) has reduced its debt by 214.336 million USD in the last 12 months
Capital Structure:
BIO-RAD LABORATORIES INC. ( BIO ) Interest-bearing Debt ($MM) as of last quarter is 1201
BIO-RAD LABORATORIES INC. ( BIO ) Annual Working Capital Investments ($MM) are -17
BIO-RAD LABORATORIES INC. ( BIO ) Book Value ($MM) as of last quarter is 7487
BIO-RAD LABORATORIES INC. ( BIO ) Debt/Capital as of last quarter is 16%
Other Balance Sheet Stats:
BIO-RAD LABORATORIES INC. ( BIO ) has 410 million in cash on hand as of last quarter
BIO-RAD LABORATORIES INC. ( BIO ) has 497 million of liabilities due within 12 months, and long term debt 1200 as of last quarter
BIO-RAD LABORATORIES INC. ( BIO ) has 28 common shares outstanding as of last quarter
BIO-RAD LABORATORIES INC. ( BIO ) has 0 million USD of preferred stock value
Academic Scores:
BIO-RAD LABORATORIES INC. ( BIO ) Altman Z-Score is 3.49 as of last quarter
BIO-RAD LABORATORIES INC. ( BIO ) Piotroski Score is 7.00 as of last quarter
Corporate Governance:
BIO-RAD LABORATORIES INC. ( BIO ) largest shareholder is owning shares at 0.00 ($MM) value
Last Andrew J.(an insider) Sold 3000 shares of BIO-RAD LABORATORIES INC. ( BIO ) for the amount of $989815.20 on 2024-09-06
15.57% of BIO-RAD LABORATORIES INC. ( BIO ) is held by insiders, and 91.29% is held by institutions
BIO-RAD LABORATORIES INC. ( BIO ) went public on 1970-01-01
Other BIO-RAD LABORATORIES INC. ( BIO ) financial metrics:
FCF:205.55
Unlevered Free Cash Flow:0.00
EPS:92.37
Operating Margin:9.92
Gross Profit Margin:54.78
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:34.89
Beta:0.91
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About BIO-RAD LABORATORIES INC. ( BIO ) :
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
DISCLAIMER
This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.